Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AtomVie, together with RLS and UPPI will bolster its distribution capabilities and allow life-saving treatments to reach more patients.
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
The Department of Paediatrics at the University of Oxford, has entered into an agreement with three Brazilian Universities, to contribute to the delivery of an undergraduate course in ‘Translational Science’, starting in 2024.The course, which will e
NEW YORK, Feb. 16, 2024 -- Sharps Technology, Inc., , an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is working to create new...
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms1GenePHIT is a clinical trial to evaluate the safety and efficacy of the one-time administration of AB-1002 and will include the largest number...